Activity in 2013

ACTIVITY IN 2013

(Unaudited data)

CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2013

thousands of euros	2012	2013	Variation at current exchange rates	Variation at constant exchange rates
France	325,900	346,965	+ 6.5%	+ 6.5%
International :	240,394	270,766	+ 12.6%	+ 15.2%
Incl. Europe excluding France	184,489	204,283	+ 10.7%	+ 12.8%
Incl. North America	45,345	53,364	+ 17.7%	+ 22.2%
Incl. Other countries	10,560	13,119	+ 24.2%	+ 27.9%
Group Total	566,294	617,731	+ 9.1%	+ 10.2%

thousands of euros	2012	2013	Variation at current exchange rates	Variation at constant exchange rates
Non-proprietary Homeopathic Medicines	292,025	305,739	+ 4.7%	+ 4.9%
OTC Specialties	273,776	311,581	+ 13.8%	+ 15.8%
Other	493	411	- 16.6%	- 21.5%
Group Total	566,294	617,731	+ 9.1%	+ 10.2%

QUARTERLY ACTIVITY IN 2013 (variation at current rate)

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

thousands of euros

2012

2013

Var.

13/12

2012

2013

Var.

13/12

2012

2013

Var.

13/12

2012

2013

Var.

13/12

France

74,188

84,270

+ 13.6%

71,210

75,327

+ 5.8%

88,028

92,596

+ 5.2%

92,474

94,772

+ 2.5%

International :

54,904

73,751

+ 34.3%

41,216

42,436

+ 3.0%

69,839

76,890

+ 10.1%

74,435

77,689

+ 4.4%

Incl. Europe excluding France

41,807

54,334

+ 30.0%

28,889

29,047

+ 0.5%

55,345

61,256

+ 10.7%

58,448

59,646

+ 2.0%

Incl. North America

10,285

15,562

+ 51.3%

9,861

10,017

+ 1.6%

11,136

12,153

+ 9.1%

14,063

15,632

+ 11.2%

Incl. Other countries

2,812

3,855

+ 37.1%

2,466

3,372

+ 36.7%

3,358

3,481

+ 3.7%

1,924

2,411

+ 25.3%

Group Total

129,092

158,021

+ 22.4%

112,426

117,763

+ 4.7%

157,867

169,486

+ 7.4%

166,909

172,461

+ 3.3%

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

thousands of euros

2012

2013

Var.

13/12

2012

2013

Var.

13/12

2012

2013

Var.

13/12

2012

2013

Var.

13/12

Non-proprietary Homeopathic Medicines

73,427

79,062

+ 7.7%

70,206

73,035

+ 4.0%

69,959

73,597

+ 5.2%

78,433

80,045

+ 2.1%

OTC Specialties

55,576

78,866

+ 41.9%

42,007

44,600

+ 6.2%

87,811

95,813

+ 9.1%

88,382

92,302

+ 4.4%

Other

+ 4.5%

213

128

- 39.9%

- 21.6%

114

+ 21.3%

Group Total

129,092

158,021

+ 22.4%

112,426

117,763

+ 4.7%

157,867

169,486

+ 7.4%

166,909

172,461

+ 3.3%

HIGHLIGHTS OF THE FOURTH QUARTER

Sales revenue in the fourth quarter of 2013 grew by 3.3% (5% at current rate) particularly in favour of winter specialties in France, the United States and Spain.

Given the business increase and the control of the costs, the 2013 operating income will grow very significantly in comparison to 2012.

On December 31, 2013, the group's net cash position is close to 160 million euros.

In the United States, the settlement agreement aimed to put an end to the class action proceeding in California about the Children's Coldcalm^® medicine obtained final approval from the Los Angeles Court on November 6, 2013. Since no appeal has been filed, this settlement has come into force.

A provision of one million US dollars was recorded for this litigation in 2011 covering all the costs relating to this settlement.

MEETING OF THE CENTRAL WORKS COUNCIL

On January 24, 2014, the Central Works Council of Boiron SA met within the frame of an information-consultation procedure. The General Management announced its intention to:

Merge the two distribution facilities located in the Lyon area on the site of Francheville. This merger should not lead to job losses.

Reorganize the IT department of Boiron SA. This project, which might have social consequences, could involve around fifty jobs until 2018.

Our next update: March 19, 2014, after the close of the stock market, publication of 2013 results.

Financial information manager: Philippe MONTANT

Contact for financial information: Véronique BOUSCAYROL

Investor relations: +33 (0) 4.78.45.63.43 - e-mail: [email protected]

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at : www.boiron.com

Information réglementée
Communiqués au titre de l'obligation d'information permanente :

- Communiqué sur comptes, résultats, chiffres d'affaires

Communiqué intégral et original au format PDF :

http://www.actusnews.com/documents_communiques/ACTUS-0-34689-cp-boiron_240114.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Quelle: Actusnews